Sources and updates, March 26
Sources and updates for the week of March 26 include paxlovid for Long COVID, vaccination rates by state, a pathogenic fungus, and more.
Read MoreTag: vaccination data
The future of COVID-19 vaccines needs more data
On Thursday, the FDA’s Vaccines and Related Biological Products Advisory Committee (or VRBPAC) met to discuss the future of COVID-19 vaccines. While the committee readily agreed that our current, Omicron-specific shots are working well and should be used more broadly, it had a hard time answering other questions about future vaccine regimens—largely due to a lack of good data.
Read MoreNational numbers, October 16
While official case numbers remain low compared to past fall seasons—both national cases and hospital admissions dropped again this week—signals of a coming fall surge are accumulating from wastewater and local data. According to Biobot’s dashboard, the coronavirus continues to spread in the Northeast at higher levels than the rest of the country with a new uptick this week.
Read MoreSources and updates, May 1
Featured sources for the week of May 1 include vaccination rates in nursing homes, neighborhood-level health disparities, access to hospital services, and more.
Read MoreAll the U.S.’s COVID-19 metrics are flawed
This week, I had a big retrospective story published at FiveThirtyEight: I looked back at the major metrics that the U.S. has used to track COVID-19 over the past two years—and how our country’s fractured public health system hindered our use of each one.
Read MoreCOVID source callout: Still no state-by-state data on vaccinations by race/ethnicity
It is now over a year into the U.S.’s vaccine rollout, and the CDC is still failing to publicly share data on vaccinations by state and race/ethnicity. I actually wrote a callout post about this in March 2021, and nothing has changed since then!
Read MoreSources and updates, March 13
Sources and updates for the week of March 13 include vaccine data annotations, free rapid tests, a combination of Delta and Omicron, and more.
Read MoreSources and updates, February 6
Featured sources for the week of February 6 include vaccination coverage among dialysis patients and in the LGBTQ+ community, and the effectiveness of masking for children.
Read MoreBoosters for all adults: Why eligibility expanded, and what it means for you
On Friday morning, the FDA authorized booster shots of Pfizer’s and Moderna’s COVID-19 vaccines for all adults in the U.S., six months after their first two doses. The CDC’s vaccine advisory committee voted to support this expanded booster eligibility that afternoon, and CDC leadership signed off on it a few hours later.
Read MoreAnother COVID-19 endgame take
Trevor Bedford, computational virologist at the Fred Hutchinson Cancer Research Center—and widely regarded expert on coronavirus variants—wrote a useful Twitter thread this week. In the thread, Bedford provides his take on the “COVID-19 endgame.” In other words, what will happen once the virus reaches endemic levels?
Read More